1 year return (CAGR)
-74.46%
Sangamo Therapeutics Inc Exchange (NASDAQ, USD)
SGMO
0.07
-0.01 (-4.29%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-50.53%
5 year return (CAGR)
-55.77%
10 year return (CAGR)
-29.65%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
83.27M
Price/Sales
2.11
Ent value
136.33M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.21 |
| Daily high | 0.21 |
| Daily low | 0.19 |
| Daily Volume | 3.36M |
| All-time high | 49.63 |
| 1y analyst estimate | 1.50 |
| Beta | 1.29 |
| EPS (TTM) | -0.32 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| SGMO | S&P500 | |
| Current price drop from All-time high | -99.85% | -1.95% |
| Highest price drop | -99.62% | -56.47% |
| Date of highest drop | 24 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -83.96% | -10.68% |
| Avg time to new high | 285 days | 12 days |
| Max time to new high | 6450 days | 1805 days |
News
No items found